Bolt Biotherapeutics
NASDAQ:BOLTBolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Canada Zinc Metals
CVE:CZXCanada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
Max Resource
CVE:MXRMax Resource Corp. engages in the acquisition and exploration of mineral properties in Canada, Peru, and Colombia. The company holds interests in the Choco gold project covering 250 square kilometers; North Choco gold-copper project covering 250 square kilometers; Gachala copper project covering 164 square kilometers; Novita project covering 10,790 hectares located in Colombia; and Cesar copper silver project, which covers an area of approximately 2,000 hectares located in Colombia. It also holds 100% interest in the RT Gold property consists of two contiguous mineral concessions covering 1,983 hectares and sits along the Condor mountain chain of northern Peru. The company was formerly known as Vancan Capital Corp. and changed its name to Max Resource Corp. in May 2004. Max Resource Corp. was incorporated in 1994 and is headquartered in Vancouver, Canada.